Humacyte Inc stock is traded at $0.3955, with a volume of 5,965,602. It is down -12.11% in the last 24 hours and down -20.90% over the past month. Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Previous Close:
$0.45
Open:
$0.44
24h Volume:
5,965,602
Relative Volume:
1.54
Market Cap:
$109.87M
Revenue:
$2.02M
Net Income/Loss:
-$97.59M
P/E Ratio:
-
EPS:
-$0.5747
Net Cash Flow:
-$102.38M
1W Performance:
-15.82%
1M Performance:
-20.90%
6M Performance:
-56.15%
1Y Performance:
-72.72%
1-Day Range:
$0.387$0.4486
1-Week Range:
$0.385$0.475
52-Week Range:
$0.337$1.53
Humacyte Inc Stock (HUMA) Company Profile
Name
Humacyte IncSector
HealthcareIndustry
BiotechnologyPhone
919-313-9633Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS